pargyline has been researched along with Fibrosarcoma in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Fibrosarcoma: A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Satoh, M | 1 |
Cherian, MG | 1 |
Imura, N | 1 |
Shimizu, H | 1 |
1 other study available for pargyline and Fibrosarcoma
Article | Year |
---|---|
Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis.
Topics: Alkynes; Animals; Cisplatin; Colonic Neoplasms; Cysteine; Doxorubicin; Drug Resistance; Female; Fibr | 1994 |